1 false false false false false false false false false false true false false false false false false No description of principal activity 2025-02-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 04352134 2025-02-01 2026-01-31 04352134 2026-01-31 04352134 2025-01-31 04352134 2024-02-01 2025-01-31 04352134 2025-01-31 04352134 2024-01-31 04352134 bus:Director1 2025-02-01 2026-01-31 04352134 core:WithinOneYear 2026-01-31 04352134 core:WithinOneYear 2025-01-31 04352134 bus:Micro-entities 2025-02-01 2026-01-31 04352134 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 04352134 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 04352134 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 04352134 bus:FullAccounts 2025-02-01 2026-01-31
COMPANY REGISTRATION NUMBER: 04352134
JULES PHARMA LIMITED
Filleted Unaudited Financial Statements
31 January 2026
JULES PHARMA LIMITED
Statement of Financial Position
31 January 2026
2026
2025
£
£
Fixed assets
18
25
----
----
Current assets
22,625
23,053
Creditors: amounts falling due within one year
13,109
23,979
--------
--------
Net current assets/(liabilities)
9,516
( 926)
-------
----
Total assets less current liabilities
9,534
( 901)
Accruals and deferred income
600
600
-------
-------
8,934
(1,501)
-------
-------
Capital and reserves
8,934
( 1,501)
-------
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
2. Director's advances, credits and guarantees
The company is £13,108 indebted to the Director at the end of the year
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 8 April 2026 , and are signed on behalf of the board by:
Mr A N Aghadiuno
Director
Company registration number: 04352134
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 10 Lyndhurst Road, Coulsdon,, Surrey,, CR5 3HT.